title: [RESTLESS LEGS SYNDROME--WILLIS-EKBOM DISEASE].
abstract: Restless legs syndrome (RLS) is a sensorimotor disorder with a high prevalence (10% in Caucasian populations). It is a purely clinical diagnosis characterized by an urge to move the lower limbs usually accompanied or caused by unpleasant sensations in the legs with an improvement in symptoms with movement. These sensations occur during inactivity or at rest and worsen in the evening or at night. RLS may not only impact the quality of life for an individual, but may also increase mortality. Disease markers such as genetic predispositions have been identified, as well as reduced iron stores with altered intracerebral iron homeostasis and dopaminergic dysfunction. Medication is often necessary in severe forms, with low doses of dopaminergic agonists being the first-line of treatment. The use of α2δ ligands is an alternative. Finally benzodiazepines and opioid medications can be effective in refractory cases. In less severe forms of RLS, a non-pharmacological approach is usually sufficient with avoidance of stimulants and correction of contributing factors.
authors.forename: Élisabeth
authors.initials: É
authors.lastname: Ruppert
authors.forename: Marc
authors.initials: M
authors.lastname: Bataillard
authors.forename: Patrice
authors.initials: P
authors.lastname: Bourgin
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D006801:Humans; D015995:Prevalence; D011788:Quality of Life; D012148:Restless Legs Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers